Table 1.
Somnogenic Substances/Immune Mediators | Effects NREMS | Effects REMS | CRS | References |
---|---|---|---|---|
Interleukin-1 | ↑ ↔ ↓ | + | Krueger5, Lennard,46 Mullol47 | |
Interleukin-1 Receptor Antagonist | ↓ | Opp 48 | ||
Interleukin-4 | ↓ | + | Krueger5, Kushikata16, | |
Interleukin-6 | ↑ ↔ ↓ | + | Bauer49, Vgontzas50, Hogan51, Ghaffar52 | |
Interleukin-10 | ↓ | + | Krueger5, Kushikata15, Opp53, Toth54, Jyonouchi 55 | |
Interleukin-13 | ↓ | + | Kubota17, al Ghamdi,14 Reh56 | |
Inferferon alpha | ↑ ↔ ↓ | ↓ | Bohnet57 | |
Soluble tumor necrosis factor receptor | ↓ | Kubota58 | ||
Tissue Growth Factor Beta | ↓ | + | Kubota,17 Kuo13 | |
Histamine | ↓ | + | Tashiro,59 | |
TLR | ↑ | ↓ | + | Wisor,60 Sartorius,61 Lane62 |
Prostaglandin | ↑ ↔ ↓ | ↑ | Sri Kantha,63 Hayaishi,64 Urade,65 Krueger66 |
NREMS, non-rapid eye movement sleep; REMS, rapid eye movement sleep; CRS, chronic rhinosinusitis; TLR, toll-like receptor. “↑”,”↔”, and “↓” indicate mean influence on NREMS or REMS.